1. Home
  2. SWX vs IMNM Comparison

SWX vs IMNM Comparison

Compare SWX & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Gas Holdings Inc. (DE)

SWX

Southwest Gas Holdings Inc. (DE)

HOLD

Current Price

$81.87

Market Cap

5.9B

Sector

Utilities

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$21.68

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SWX
IMNM
Founded
1931
2006
Country
United States
United States
Employees
2453
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9B
2.5B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
SWX
IMNM
Price
$81.87
$21.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
10
Target Price
★ $87.40
$32.80
AVG Volume (30 Days)
539.5K
★ 1.1M
Earning Date
05-05-2026
05-08-2026
Dividend Yield
★ 2.70%
N/A
EPS Growth
★ 120.29
51.40
EPS
★ 2.49
N/A
Revenue
★ $5,433,972,000.00
$6,941,000.00
Revenue This Year
$18.48
N/A
Revenue Next Year
$2.61
$1,127.34
P/E Ratio
$33.18
★ N/A
Revenue Growth
★ 9.56
N/A
52 Week Low
$76.74
$11.09
52 Week High
$94.47
$30.06

Technical Indicators

Market Signals
Indicator
SWX
IMNM
Relative Strength Index (RSI) 28.10 31.94
Support Level $81.21 $19.39
Resistance Level $89.83 $23.25
Average True Range (ATR) 1.54 1.16
MACD -0.44 -0.44
Stochastic Oscillator 7.92 10.66

Price Performance

Historical Comparison
SWX
IMNM

About SWX Southwest Gas Holdings Inc. (DE)

Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution segment. The Natural gas distribution segment encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. Its division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: